Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Np resident lecture-wmdisease2009-slideshareupload

2,097 views

Published on

Published in: Health & Medicine
  • Be the first to comment

Np resident lecture-wmdisease2009-slideshareupload

  1. 1. DISEASES OF WHITE MATTER Charles L. White, III, M.D. November 19, 2009
  2. 2. Description of myelin (1854)
  3. 3. Oligodendroglia <ul><li>“ Few processes” </li></ul><ul><li>Cell membranes are enriched in lipid-rich myelin </li></ul><ul><ul><li>Phospholipids </li></ul></ul><ul><ul><li>Glycolipids </li></ul></ul><ul><ul><li>Cholesterol </li></ul></ul><ul><ul><li>Proteins </li></ul></ul>
  4. 4. Oligodendroglia in white matter
  5. 5. Oligodendroglia in white matter
  6. 6. Oligodendroglia in white matter
  7. 7. Oligodendroglia: Myelin stain
  8. 8. Oligodendroglia: Nodes of Ranvier <ul><li>Saltatory conduction: action potentials “jump” from node to node, resulting in more rapid signal conduction along the axon </li></ul>
  9. 9. Phenomenon of “selective vulnerability” <ul><li>A given insult will produce damage in restricted brain regions or components </li></ul><ul><li>Basis of selective vulnerability (the brain is the most inhomogeneous organ in the body): </li></ul><ul><ul><li>location </li></ul></ul><ul><ul><li>biochemical properties (e.g., neurotransmitter) </li></ul></ul><ul><ul><li>other factors </li></ul></ul><ul><li>Determining basis of selective vulnerability in a particular disease process may lead to: </li></ul><ul><ul><li>Improved understanding of the mechanism of damage </li></ul></ul><ul><ul><li>Design of specific treatment for the disease </li></ul></ul>
  10. 10. Demyelinating disorders: Substrates of selective vulnerability <ul><li>Enzymes associated with myelin production or maintenance (leukodystrophies) </li></ul><ul><li>Antigens associated with myelin (immune-mediated disorders) </li></ul>
  11. 11. Primary demyelination vs. secondary loss of myelin <ul><li>Primary demyelination: </li></ul><ul><ul><li>Dysmyelinating and myelinoclastic disorders (the subject of this lecture) </li></ul></ul><ul><li>Secondary loss of myelin: </li></ul><ul><ul><li>Loss of myelin due to degeneration of axons (Wallerian degeneration) </li></ul></ul>
  12. 12. Secondary loss of myelin: Amyotrophic lateral sclerosis
  13. 13. Primary demyelinating disorders <ul><li>Dysmyelinating (Leukodystrophies) </li></ul><ul><ul><li>Metabolic derangements </li></ul></ul><ul><ul><ul><li>Abnormal synthesis or turnover of myelin </li></ul></ul></ul><ul><ul><ul><li>Lysosomal or peroxisomal enzyme deficiencies </li></ul></ul></ul><ul><li>Myelinoclastic </li></ul><ul><ul><li>Immune-mediated </li></ul></ul><ul><ul><ul><li>Examples </li></ul></ul></ul><ul><ul><ul><ul><li>Multiple sclerosis </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Parainfectious demyelinating disorders </li></ul></ul></ul></ul><ul><ul><li>Others: infectious, toxic </li></ul></ul>
  14. 14. Demyelinating disorders: General features <ul><li>Myelin loss with relative sparing of axons </li></ul><ul><li>CNS has only limited capacity for remyelination (vs. PNS) </li></ul><ul><li>Clinical manifestations due to interruption of saltatory conduction, and some secondary injury to axons </li></ul><ul><li>Clinical manifestations are primarily motor in nature </li></ul>
  15. 15. Dysmyelinating disorders (leukodystrophies) <ul><li>Krabbe disease (Globoid cell leukodystrophy) </li></ul><ul><li>Adrenoleukodystrophy (ALD) </li></ul><ul><ul><li>Adrenomyeloneuropathy (AMN) </li></ul></ul><ul><li>Metachromatic leukodystrophy (MLD) </li></ul>
  16. 16. Dysmyelinating disorders (leukodystrophies) <ul><li>Clinical features </li></ul><ul><ul><li>Inherited </li></ul></ul><ul><ul><ul><li>Autosomal recessive (most) </li></ul></ul></ul><ul><ul><ul><li>X-linked recessive (ALD) </li></ul></ul></ul><ul><ul><li>Age of onset varies by disease </li></ul></ul><ul><ul><ul><li>Infancy </li></ul></ul></ul><ul><ul><ul><ul><li>Krabbe disease, MLD </li></ul></ul></ul></ul><ul><ul><ul><li>Childhood and adolescence </li></ul></ul></ul><ul><ul><ul><ul><li>ALD, MLD </li></ul></ul></ul></ul><ul><ul><ul><li>Adulthood </li></ul></ul></ul><ul><ul><ul><ul><li>AMN, MLD </li></ul></ul></ul></ul><ul><ul><li>Younger onset usually associated with more severe (often fatal) disease </li></ul></ul>
  17. 17. Leukodystrophy: Confluent demyelination
  18. 18. Leukodystrophy: Subcortical “U-fiber” sparing
  19. 19. Leukodystrophies: Pathogenesis Disease Enzyme deficiency Toxic agent Krabbe disease Galactocerebroside β -galactosidase (GALC) Galactosylsphingosine (psychosine) Metachromatic leukodystrophy (MLD) Arylsulfatase A Sulfatides Adrenoleukodystrophy (ALD) ABCD1 VLCFA
  20. 20. Krabbe disease (globoid cell leukodystrophy) <ul><li>Autosomal recessive inheritance </li></ul><ul><li>GALC gene on chromosome 14 </li></ul><ul><li>Rapidly progressive clinical course </li></ul><ul><ul><li>Onset by age 6 months </li></ul></ul><ul><ul><li>Death by age 2 years </li></ul></ul><ul><li>Multinucleated “globoid cells” derived from microglia (macrophages) </li></ul><ul><li>Hyporeflexia due to PNS involvement </li></ul>
  21. 21. Krabbe disease
  22. 22. Krabbe disease: “Globoid” cells
  23. 23. Krabbe disease (LFB/PAS)
  24. 24. Metachromatic leukodystrophy <ul><li>Autosomal recessive inheritance </li></ul><ul><li>Arylsulfatase gene on chromosome 22 </li></ul><ul><li>Late infantile, juvenile, and adult onset forms </li></ul><ul><li>Lower enzyme activity associated with earlier onset </li></ul><ul><li>Metachromatic material </li></ul><ul><ul><li>CNS: macrophages </li></ul></ul><ul><ul><li>PNS: Schwann cells, macrophages, axons </li></ul></ul>
  25. 25. Metachromatic leukodystrophy: Peripheral nerve involvement
  26. 26. Adrenoleukodystrophy <ul><li>X-linked recessive inheritance </li></ul><ul><li>ALD gene encodes “ATP binding cassette, subfamily D, member 1” (ABCD1) </li></ul><ul><ul><li>Normal function is to transport VLCFA’s into peroxisome for catabolism </li></ul></ul><ul><li>VLCFA’s accumulate in blood, brain, and adrenal cortex </li></ul><ul><li>Chronic CNS lesions may show marked inflammatory infiltrate at periphery </li></ul>
  27. 27. Adrenoleukodystrophy: Asymmetrical frontal demyelination
  28. 28. Adrenoleukodystrophy
  29. 29. Adrenoleukodystrophy
  30. 30. Adrenoleukodystrophy: Adrenal cortical cytoplasmic inclusions
  31. 31. Adrenomyeloneuropathy <ul><li>Occurs in same families as ALD </li></ul><ul><li>Onset in adulthood </li></ul><ul><li>May be seen in heterozygous females </li></ul><ul><li>Clumsiness and ataxia due to involvement of long tracts of spinal cord and peripheral nerve </li></ul><ul><li>Adrenal insufficiency also common </li></ul>
  32. 32. Myelinoclastic disorders <ul><li>Multiple sclerosis </li></ul><ul><li>Parainfectious disorders </li></ul>
  33. 33. Multiple sclerosis: Clinical features <ul><li>Lesions distributed “over time and space” </li></ul><ul><ul><li>Episodic (exacerbations and remissions) </li></ul></ul><ul><ul><li>Multifocal </li></ul></ul><ul><ul><ul><li>Cerebrum </li></ul></ul></ul><ul><ul><ul><li>Brainstem </li></ul></ul></ul><ul><ul><ul><li>Cerebellum </li></ul></ul></ul><ul><ul><ul><li>Spinal cord </li></ul></ul></ul><ul><ul><ul><li>Optic tracts </li></ul></ul></ul><ul><li>Debilitating </li></ul>
  34. 34. Multiple sclerosis: Epidemiology <ul><li>Age and gender </li></ul><ul><ul><li>Onset predominantly in young to middle aged adults (peak onset in 20’s) </li></ul></ul><ul><ul><li>Frequency of relapses decreases over course of disease </li></ul></ul><ul><ul><li>2:1 female:male predominance </li></ul></ul><ul><li>Geographic distribution </li></ul><ul><ul><li>Higher latitudes (northern US, Canada, northern Europe) </li></ul></ul><ul><ul><li>Partly a result of genetic differences between populations and subsequent migration patterns of susceptible groups </li></ul></ul>
  35. 35. Multiple sclerosis: Laboratory findings <ul><li>Cerebrospinal fluid </li></ul><ul><ul><li>Myelin basic protein (MBP) </li></ul></ul><ul><ul><li>Oligoclonal bands </li></ul></ul><ul><ul><li>Increased IgG </li></ul></ul><ul><li>Neuroimaging </li></ul><ul><ul><li>MRI especially useful in imaging white matter lesions </li></ul></ul>
  36. 36. Multiple sclerosis: Widely distributed lesions
  37. 37. Multiple sclerosis: Widely distributed lesions
  38. 38. Multiple sclerosis: Periventricular plaques
  39. 39. Multiple sclerosis: Gross plaque morphology
  40. 40. Multiple sclerosis: Gross plaque morphology
  41. 41. Multiple sclerosis: active plaque
  42. 42. Multiple sclerosis Active plaque
  43. 43. Multiple sclerosis: Active demyelination Myelin stain (blue) with PAS counterstain CD68 (histiocytes)
  44. 44. Multiple sclerosis: Microscopic plaque morphology H&E Myelin stain CD68 (histiocytes) Axon stain H&E
  45. 45. Multiple sclerosis: Relative axonal preservation Normal white matter Demyelinated plaque
  46. 46. Multiple sclerosis: Pathogenesis <ul><li>Autoimmune factors </li></ul><ul><ul><li>Initiated by CD4+ T cells reacting with myelin antigens (e.g., MBP) </li></ul></ul><ul><ul><li>Demyelination effected by activated macrophages </li></ul></ul><ul><li>Genetic factors </li></ul><ul><ul><li>15X increased risk among first-degree relatives </li></ul></ul><ul><ul><ul><li>Even higher among monozygotic twins </li></ul></ul></ul><ul><ul><li>Susceptibility linked to MHC DR2 haplotype </li></ul></ul><ul><li>Environmental factors </li></ul><ul><ul><li>?Microbial triggers? </li></ul></ul>
  47. 47. MS variants <ul><li>Marburg type </li></ul><ul><ul><li>Rapidly progressive, monophasic course, typically fatal </li></ul></ul><ul><li>Bal ό concentric sclerosis </li></ul><ul><ul><li>Very rare </li></ul></ul><ul><ul><li>Rapidly fatal course </li></ul></ul><ul><li>Devic neuromyelitis optica </li></ul><ul><ul><li>Lesions predominate in optic nerves, spinal cord </li></ul></ul><ul><ul><li>Plaques more inflammatory and extensive </li></ul></ul>
  48. 48. Animal models of MS <ul><li>Experimental allergic encephalomyelitis (EAE) </li></ul><ul><ul><li>Immunization of animals with myelin or myelin components results in autoimmune CNS demyelination </li></ul></ul><ul><li>Theiler virus encephalomyelitis </li></ul><ul><ul><li>Brain infection induces similar CNS demyelination </li></ul></ul><ul><li>Important for understanding pathogenesis and testing potential therapies </li></ul>
  49. 49. Parainfectious disorders <ul><li>Inflammatory demyelination </li></ul><ul><li>Autoimmune mechanism </li></ul><ul><li>Typically monophasic, usually following a “flu-like illness” or vaccination </li></ul>
  50. 50. Parainfectious disorders <ul><li>Acute disseminated encephalomyelitis (ADEM) </li></ul><ul><li>Acute hemorrhagic leukoencephalopathy </li></ul>
  51. 51. ADEM
  52. 52. ADEM Small foci of perivenular demyelination

×